Limits...
A comparative study of Shvasahara Leha and Vasa Haritaki Avaleha in the management of Tamaka Shvasa (Bronchial Asthma).

Sharma M, Dave AR, Shukla VD - Ayu (2011)

Bottom Line: Tamaka Shvasa is a type of Shvasa Roga associated with difficulty in breathing as a result of which the patient prefers to sit in bed to get relief from his discomfort.Movement of air through Pranavaha Srotas is hampered in this disease resulting in the cry of organ heading toward complete failure for want of air.The effects of therapy in both groups were assessed by a specially prepared proforma.

View Article: PubMed Central - PubMed

Affiliation: Lecturer, Department of Kaya Chikitsa, Government Ayurved College, Junagadh, Gujarat, India.

ABSTRACT
Tamaka Shvasa is a type of Shvasa Roga associated with difficulty in breathing as a result of which the patient prefers to sit in bed to get relief from his discomfort. Movement of air through Pranavaha Srotas is hampered in this disease resulting in the cry of organ heading toward complete failure for want of air. Tamaka Shvasa is well known for its episodic and chronic course which comes under the life-threatening disease. It is analogous to bronchial asthma due to similarity in symptoms, pathogenesis, onset, causes, and precipitating factors. In this study, 40 patients of Tamaka Shvasa were registered and randomly divided into two groups, out of which 31 patients completed the treatment. In Group A, Shvasahara Leha (5 g twice a day) was given for 2 months, while in Group B Vasa Haritaki Avaleha (5 g twice a day) was given for 2 months and follow-up was done for one month in both groups. The effects of therapy in both groups were assessed by a specially prepared proforma. Diagnosis was done by adult asthma diagnosis questionnaire and differential diagnosis with COPD (Chronic obstructive pulmonary disease) was done by differential diagnosis questionnaire as both these conditions are overlapping. The results of the study indicate that the Vasa Haritaki Avaleha provided better relief than Shvasahara Leha in Tamaka Shvasa.

No MeSH data available.


Related in: MedlinePlus

Effect on PEFR *Significant
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3361925&req=5

Figure 1: Effect on PEFR *Significant

Mentions: It was observed that both the groups showed statistically significant results, i.e. P<0.01 and P<0.05, respectively, on PEFR. It was observed that 12.9% improvement was found in PEFR in Group A and 18.26% relief in Group B [Graph 1].


A comparative study of Shvasahara Leha and Vasa Haritaki Avaleha in the management of Tamaka Shvasa (Bronchial Asthma).

Sharma M, Dave AR, Shukla VD - Ayu (2011)

Effect on PEFR *Significant
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3361925&req=5

Figure 1: Effect on PEFR *Significant
Mentions: It was observed that both the groups showed statistically significant results, i.e. P<0.01 and P<0.05, respectively, on PEFR. It was observed that 12.9% improvement was found in PEFR in Group A and 18.26% relief in Group B [Graph 1].

Bottom Line: Tamaka Shvasa is a type of Shvasa Roga associated with difficulty in breathing as a result of which the patient prefers to sit in bed to get relief from his discomfort.Movement of air through Pranavaha Srotas is hampered in this disease resulting in the cry of organ heading toward complete failure for want of air.The effects of therapy in both groups were assessed by a specially prepared proforma.

View Article: PubMed Central - PubMed

Affiliation: Lecturer, Department of Kaya Chikitsa, Government Ayurved College, Junagadh, Gujarat, India.

ABSTRACT
Tamaka Shvasa is a type of Shvasa Roga associated with difficulty in breathing as a result of which the patient prefers to sit in bed to get relief from his discomfort. Movement of air through Pranavaha Srotas is hampered in this disease resulting in the cry of organ heading toward complete failure for want of air. Tamaka Shvasa is well known for its episodic and chronic course which comes under the life-threatening disease. It is analogous to bronchial asthma due to similarity in symptoms, pathogenesis, onset, causes, and precipitating factors. In this study, 40 patients of Tamaka Shvasa were registered and randomly divided into two groups, out of which 31 patients completed the treatment. In Group A, Shvasahara Leha (5 g twice a day) was given for 2 months, while in Group B Vasa Haritaki Avaleha (5 g twice a day) was given for 2 months and follow-up was done for one month in both groups. The effects of therapy in both groups were assessed by a specially prepared proforma. Diagnosis was done by adult asthma diagnosis questionnaire and differential diagnosis with COPD (Chronic obstructive pulmonary disease) was done by differential diagnosis questionnaire as both these conditions are overlapping. The results of the study indicate that the Vasa Haritaki Avaleha provided better relief than Shvasahara Leha in Tamaka Shvasa.

No MeSH data available.


Related in: MedlinePlus